SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3561 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1460Yet, another sucker at REGN. Didn't took long to show his face. investor.rMiljenko Zuanic-9/7/2011
1459JIm, I think that Amgen have results from this trial, as they already initiated Miljenko Zuanic-9/6/2011
1458I was done reading reading "under the candle" only 2 days after Irene,Biotech Jim-9/6/2011
1457Trap-oncology BDA plan: US-2LmCRC Sept-11 EU-2LmCRC Q4-11 Jim, you did not rMiljenko Zuanic-9/6/2011
1456Hence the FOV prefix to the code name for these compounds. Thanks for the updatBiotech Jim-9/6/2011
1455Quick search. They got those programs in their acquisition of Fovea. en.sanofirkrw-9/6/2011
1454Today sanofi-Aventis group had an investor day presentation, and they updated thBiotech Jim-9/6/2011
1453Hi Jim, others,... Glad that Irene 'fun" is over and things are graduMiljenko Zuanic-8/29/2011
1452I am aware of the ISIS/BMY effort, antisense (since Koblan left ALNY I have my dBiotech Jim18/29/2011
1451ALNY is about to enter Phase 1 as well with their own candidate.mcbio-8/28/2011
1450Y'all are aware that Isis/BMS also have a program for this target? A bit betuck-8/28/2011
1449Hi Miljenko- Nice summary that you posted. I agree that the PCSK9Ab may be a sBiotech Jim-8/27/2011
1448Good article on PCSK9 uk.reuters.com One day this may be REGN biggest driverMiljenko Zuanic-8/27/2011
1447REGN files 8-K on CRVO (Copernicus) study update, 1 year study results and conclBiotech Jim-8/22/2011
1446CMC part of the BLA is usually filed first, and it does take time to properly evMiljenko Zuanic-8/17/2011
1445Schleifer quote in an answer to the second question on new CMC data needs to be Biotech Jim-8/17/2011
1444"Regeneron Announces Review of Biologics License Application for EYLEA (aflMiljenko Zuanic-8/17/2011
1443I do not know what blockage level for IL6-mediated response we are talking whenMiljenko Zuanic-7/14/2011
1442Yes, both JAK1 and JAK2 are downstream of IL6R. However, the RA models in micBiotech Jim-7/13/2011
1441Isn't JAK2 involved downstream of the IL2/6/12 and INFy path? So synergy witMiljenko Zuanic-7/13/2011
1440I am curious about JAK2 combo with either IL6R Ab or TNFa Ab, not Cot combo of tBiotech Jim-7/13/2011
1439TNF/IL6R or MTX/IL6R combination? Or others combo? TNF/IL6R combination, I gueMiljenko Zuanic-7/13/2011
1438SNY and REGN report on the IL6R Ab (REGN 88 or sarilumab) in RA and in anklyosinBiotech Jim-7/12/2011
1437First line HR-mPC to continue??? finance.yahoo.com After Avastin failure for Miljenko Zuanic-7/7/2011
1436Results from Advisory meeting 3 min ago: reuters.com (Reuters) - A new eye medBiotech Jim-6/17/2011
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News